Article
Targeting cytosolic phospholipase A2 α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation.
Oncotarget - 15 Dec 2014
Zheng Zhong, He Xiangyi, Xie Chanlu, Hua Sheng, Li Jianfang, Wang Tingfeng, Yao Mu, Vignarajan Soma, Teng Ying, Hejazi Leila, Liu Bingya, Dong Qihan
Abstract excerpt
A constitutive activation of protein kinase B (AKT) in a hyper-phosphorylated status at Ser473 is one of the hallmarks of anti-EGFR therapy-resistant colorectal cancer (CRC). The aim of this study was to examine the role of cytosolic phospholipase A2α (cPLA2α) on AKT phosphorylation at Ser473 and cell proliferation in CRC cells with mutation in phosphoinositide 3-kinase (PI3K). AKT phosphorylation at Ser473 was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
